These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38449718)

  • 21. [Physicians founders of orthopedic surgery in Serbia].
    Bumbasirević M; Lesić A
    Srp Arh Celok Lek; 2004; 132(5-6):198-203. PubMed ID: 15493595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Narrative Review of STAT Proteins in Diabetic Retinopathy: From Mechanisms to Therapeutic Prospects.
    Hong L; Lin Y; Yang X; Wu T; Zhang Y; Xie Z; Yu J; Zhao H; Yi G; Fu M
    Ophthalmol Ther; 2022 Dec; 11(6):2005-2026. PubMed ID: 36208390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
    Lee R; Wong TY; Sabanayagam C
    Eye Vis (Lond); 2015; 2():17. PubMed ID: 26605370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PROF. DR. MED. DR. PHIL. DR. MED. H.C. DR. MED. H.C. PAUL DIEPGEN ON THE 24TH NOVEMBER, 1963].
    VON BRUNN
    Dtsch Med Wochenschr; 1963 Nov; 88():2357-8. PubMed ID: 14117835
    [No Abstract]   [Full Text] [Related]  

  • 25. [HLA-DR as a criterion in the selection of organ recipients].
    Speiser P; Pausch V
    Wien Med Wochenschr; 1986 Feb; 136(4):89-95. PubMed ID: 3458344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of human flavor perception and discrimination of the fat content in food using DR A-Not A and 3-AFC methods.
    Kim SM; Kim JE; Lee HS
    Food Sci Biotechnol; 2021 Jun; 30(6):815-822. PubMed ID: 34249387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic modifications and potential new treatment targets in diabetic retinopathy.
    Perrone L; Matrone C; Singh LP
    J Ophthalmol; 2014; 2014():789120. PubMed ID: 25165577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of serological and molecular results for HLA-DR typing in 120 Thai subjects.
    Nathalang O; Kupatawintu P; O'Charoen R; Sinsiri S; Saelee S; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):311-3. PubMed ID: 10774701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between iridopathy and retinopathy in diabetes.
    Bandello F; Brancato R; Lattanzio R; Galdini M; Falcomatà B
    Br J Ophthalmol; 1994 Jul; 78(7):542-5. PubMed ID: 7918265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of anti-HLA-DR antibodies from the mother to the child. Are DR antigens expressed on the placenta?
    Tongio MM; Werneburg B; Mayer S
    Tissue Antigens; 1983 Jul; 22(1):24-8. PubMed ID: 6577694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis.
    Quirant-Sánchez B; Plans-Galván O; Lucas E; Argudo E; Martinez-Cáceres EM; Arméstar F
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Estimated Glucose Disposal Rate and Type 2 Diabetic Retinopathy.
    Meng C; Xing Y; Huo L; Ma H
    Diabetes Metab Syndr Obes; 2023; 16():807-818. PubMed ID: 36959899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Enantiospecific Synthesis of the Potent Immunosuppressant FR901483 Dr. G. Scheffler and H. Seike contributed equally to this work. We thank Dr. L. B. Pasternack and Dr. D. H. Huang for NMR spectroscopic assistance, and Dr. G. Siuzdak for mass spectrometric assistance. We also thank Dr. S. Takase and Dr. H. Setoi from the Fujisawa Pharmaceutical Co. for physical data for FR901483. This work was generously supported by The Skaggs Institute for Chemical Biology, a grant from the Merck Research Laboratories, a Beckman Young Investigator Award to E.J.S., and a predoctoral fellowship from the Heiwa Nakajima Foundation to H.S.
    Scheffler G; Seike H; Sorensen EJ
    Angew Chem Int Ed Engl; 2000 Dec; 39(24):4593-4596. PubMed ID: 11169681
    [No Abstract]   [Full Text] [Related]  

  • 34. [The first physicians in Banat. I].
    Velisavljev D; Velisavljev M
    Med Pregl; 1997; 50(3-4):135-41. PubMed ID: 9229686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strong HLA-DR expression in T cell cultures after activation is necessary for IL-2-dependent proliferation.
    Effros RB; Dillard L; Zeller E; Naeim F; Walford RL
    Hum Immunol; 1983 Dec; 8(4):249-54. PubMed ID: 6606636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Professor Dr. Karl Heinrich Bauer Dr. med. h.c., Dr. jur. h.c., Dr. med. h.c. to his 75th birthday September 9, 1965].
    Linder F
    Langenbecks Arch Chir; 1965 Aug; 311(3):155-6. PubMed ID: 5322210
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prof. Dr. med., Dr. med. h.c., Dr. med. h.c., Dr. rer. nat. h.c. Max Bürger 80 years old. On the 16. November 1965].
    Seidel K
    Dtsch Z Verdau Stoffwechselkr; 1965 Nov; 25(5):257-9. PubMed ID: 4870768
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection.
    Rabin BS; Griffith BP; Hardesty RL
    J Heart Transplant; 1985 May; 4(3):293-5. PubMed ID: 3916499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an HLA-DR beta pseudogene in the DRw52 supertypic group.
    Rollini P; Mach B; Gorski J
    Immunogenetics; 1987; 25(5):336-42. PubMed ID: 3032786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparity in HLA-DR typing and mixed lymphocyte culture reactivity.
    Smith RA; Belcher R
    Ann Clin Lab Sci; 1987; 17(5):318-23. PubMed ID: 2960260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.